Niraparib
2021-KY-016
Phase 2 small_molecule completed
Quick answer
Niraparib for Platinum-resistant Recurrent Clear Cell Ovarian Cancer is a Phase 2 program (small_molecule) at Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Indication
- Platinum-resistant Recurrent Clear Cell Ovarian Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed